Low Pepsinogen I/II Ratio and High Gastrin-17 Levels Typify Chronic Atrophic Autoimmune Gastritis Patients With Gastric Neuroendocrine Tumors
Open accessThe DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Chronic atrophic autoimmune gastritis (CAAG) can lead to the development of gastric neuroendocrine tumors (gNETs) and can be accompanied by other autoimmune diseases. This study aimed to determine, in CAAG patients, the association of gNET development, the prevalence of autoimmune diseases other than CAAG, the association of autoimmunity, and gNET development with pepsinogen I, II, gastrin-17, and Helicobacter pylori infection analysis. METHODS: We determined the prevalence of gNETs and other autoimmune diseases and analyzed pepsinogen I and II, gastrin-17 serum levels, and H. pylori infection in all patients diagnosed with CAAG at our hospital between 2013 and 2017. RESULTS: A total of 156 patients were studied and in 15.4% was observed concomitant gNET. Approximately 68.6% had at least 1 other autoimmune disease at diagnosis of CAAG. Approximately 60.9% had autoimmune thyroiditis, followed by diabetes (19.9%) and autoimmune polyendocrine syndrome (12.8%). CAAG patients with and without gNET had similar rates of comorbidity with other autoimmune diseases, but the pepsinogen I/II ratio was lower in patients with gNET (1.6 vs 4.5, P = 0.018). Receiver operating characteristic curve analyses identified a pepsinogen I/II ratio <2.3 and gastrin-17 levels >29.6 pmol/L as cutoffs distinguishing CAAG patients with gNET from those without. The combined use of these cutoff correctly identified 16 of the 18 CAAG patients with gNET (P = 0.007). H. pylori infection was observed in 28.7% of cases tested but did not associate with gNET. DISCUSSION: This study suggests that a low pepsinogen I/II ratio and high gastrin-17 levels characterize patients with CAAG and gNET and confirms the frequent coexistence of CAAG with other autoimmune diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Providers should recognize that there is an established association between AIG and other autoimmune diseases, especially autoimmune thyroid disease, perhaps related to shared genetic susceptibility loci.91–93”
From AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review (2021) · cites this paper as [93]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Classification and Grading of Gastritis: The Updated Sydney System
Dixon, M. F., Genta, R. M., Yardley, J. H., & Correa, P. (1996) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199610000-00001 · Cited by 5,185
The 2019 WHO classification of tumours of the digestive system
Nagtegaal, I. D., Odze, R. D., Klimstra, D., Paradis, V., Rugge, M., Schirmacher, P., Washington, K. M., Carneiro, F., Cree, I. A., & the WHO Classification of Tumours Editorial Board (2020) · Histopathology · doi:10.1111/his.13975 · Cited by 4,192
Samloff, I. M., Varis, K., Ihamäki, T., Siurala, M., & Rotter, J. I. (1982) · PubMed · Cited by 515
Relationships Among Serum Pepsinogen I, Serum Pepsinogen II, and Gastric Mucosal Histology
Samloff, I. M., Varis, K., Ihamaki, T., Siurala, M., & Rotter, J. I. (1982) · Gastroenterology · doi:10.1016/0016-5085(82)90176-7 · Cited by 414
Autoimmune atrophic gastritis—pathogenesis, pathology and management
Neumann, W. L., Coss, E., Rugge, M., & Genta, R. M. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.101 · Cited by 406
Fallahi, P., Ferrari, S. M., Ruffilli, I., Elia, G., Biricotti, M., Vita, R., Benvenga, S., & Antonelli, A. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.09.009 · Cited by 217
Autoimmune Gastritis in Type 1 Diabetes: A Clinically Oriented Review
De Block, C. E. M., De Leeuw, I. H., & Van Gaal, L. F. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2134 · Cited by 212
Autoimmune Phenomena in Pernicious Anaemia
Doniach, D., Roitt, I. M., & Taylor, K. B. (1963) · BMJ · doi:10.1136/bmj.1.5342.1374 · Cited by 173
Diagnosis and classification of autoimmune gastritis
Toh, B. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.01.048 · Cited by 168
Risk for gastric neoplasias in patients with chronic atrophic gastritis: A critical reappraisal
Vannella, L., Lahner, E., & Annibale, B. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i12.1279 · Cited by 167
Cited by
AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review
Shah, S. C., Piazuelo, M. B., Kuipers, E. J., & Li, D. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.06.078 · Cited by 560
Diagnostic criteria and endoscopic and histological findings of autoimmune gastritis in Japan
Kamada, T., Watanabe, H., Furuta, T., Terao, S., Maruyama, Y., Kawachi, H., Kushima, R., Chiba, T., & Haruma, K. (2023) · Journal of Gastroenterology · doi:10.1007/s00535-022-01954-9 · Cited by 98
Endoscopic features and clinical importance of autoimmune gastritis
Kamada, T., Maruyama, Y., Monobe, Y., & Haruma, K. (2021) · Digestive Endoscopy · doi:10.1111/den.14175 · Cited by 95
Guidelines for diagnosis and treatment of chronic gastritis in China (2022, Shanghai )
Fang, J.-Y. (2023) · Journal of Digestive Diseases · doi:10.1111/1751-2980.13193 · Cited by 66
“An increasing trend of gastrin-17 in patients with AIG has been reported.(125) Furthermore, studies have demonstrated a positive cor-”
BackgroundHu, H., Li, R., Shao, L., Zhang, Q., Xu, R., & Zhang, S. (2022) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2022.2081061 · Cited by 31
“An Italian study suggested that a low PGI/II ratio may characterize patients with AMAG and g-NETs [3].”
Background
Metadata
- Authors
- Magris, R., De Re, V., Maiero, S., Fornasarig, M., Guarnieri, G., Caggiari, L., Mazzon, C., Zanette, G., Steffan, A., Canzonieri, V., & Cannizzaro, R.
- Affiliations
- Centro di Riferimento Oncologico (IT)
- Immunopathology and Cancer Biomarkers, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy;
- Azienda Ospedaliera Santa Maria Degli Angeli (IT)
- University of Trieste (IT)
- Corresponding author
- Cannizzaro, Renato
- ORCID
- Venue
- Clinical and Translational Gastroenterology
- Published
- 2020-09
- Volume
- 11
- Issue
- 9
- Pages
- e00238
- ISSN
- 2155-384X (ISSN-L)
- PMC
- PMC7494140
- OpenAlex
- W3093856850
- Cited by
- 46
- References
- 35
- Citations by year
- 2026: 3 · 2025: 10 · 2024: 10 · 2023: 10 · 2022: 6 · 2021: 7
- FWCI
- 4.12
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Clinical and Translational Gastroenterology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Health Sciences › Medicine › Gastroenterology › Helicobacter pylori-related gastroenterology studies
- Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
- Keywords
- gastric neuroendocrine tumor, pepsinogen I/II ratio, gastrin-17, Helicobacter pylori infection, autoimmune disease comorbidity, autoimmune thyroiditis, autoimmune polyendocrine syndrome, diabetes mellitus, biomarker cut-off values
- MeSH terms
- Adolescent, Adult, Aged, Autoimmune Diseases, Diagnosis, Differential, Female, Gastrins, Gastritis, Atrophic, Humans, Male, Middle Aged, Retrospective Studies, ROC Curve, Stomach Neoplasms, Biomarkers, Prevalence, Helicobacter pylori, Helicobacter Infections, Neuroendocrine Tumors, Pepsinogen C, Pepsinogen A, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Low Pepsinogen I/II Ratio and High Gastrin-17 Levels Typify Chronic Atrophic Autoimmune Gastritis Patients With Gastric Neuroendocrine Tumors. https://app.cochat.ai/papers/10.14309/ctg.0000000000000238
- The paper
- Magris, R., De Re, V., Maiero, S., Fornasarig, M., Guarnieri, G., Caggiari, L., Mazzon, C., Zanette, G., Steffan, A., Canzonieri, V., & Cannizzaro, R. (2020). Low Pepsinogen I/II Ratio and High Gastrin-17 Levels Typify Chronic Atrophic Autoimmune Gastritis Patients With Gastric Neuroendocrine Tumors. Clinical and Translational Gastroenterology. https://doi.org/10.14309/ctg.0000000000000238
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.